Tetra Tech's Q2 Inflection: Backlog and Margins Improve, but Structural Risks Remain

What happened

Tetra Tech reported Q2 FY26 results that the market views as an inflection point: backlog grew 8% sequentially to $4.28 billion, EBITDA margin expanded 90 basis points, and cash flow hit a record, according to a Seeking Alpha analysis. The company's digital automation portfolio and shift toward higher-margin fixed-price contracts are driving competitive differentiation and margin expansion. However, the DeepValue report underscores that Tetra Tech still faces the structural loss of over 10% of FY25 revenue from USAID cancellations and a $115 million legal contingency from Hunters Point. While Q2 shows operational momentum, the valuation at ~22x forward earnings offers thin margin of safety given ongoing policy and legal risks. The base case implies $44 value, but entry is attractive only near $34, suggesting the market may be prematurely pricing in a full recovery.

Implication

The Q2 results provide tactical support for the stock, but the longer-term thesis hinges on whether Tetra Tech can sustain ex-USAID growth above 6% and expand EBITDA margins by 50+ bps annually. Management's ability to backfill the USAID hole with defense and water contracts remains unproven over multiple quarters. The $115 million Hunters Point settlement, while being addressed, shows legacy liabilities can materialize unexpectedly. Without a pullback toward $34 or two more quarters of clear margin and revenue progression, the risk-reward at $39 is skewed to the downside. Patience is warranted; waiting for a better entry or stronger confirmation reduces downside tail risk.

Thesis delta

The Q2 inflection point adds evidence that Tetra Tech's pivot away from USAID toward higher-margin water and defense work is gaining traction, which improves the odds of the base case. However, the structural USAID hole and legal overhang remain unresolved, and the stock's valuation has rerated closer to $39 without a commensurate reduction in risk. The thesis shifts from 'waiting for a catalyst' to 'monitoring the speed and durability of the recovery'—tactical improvement does not yet justify full position sizing.